(Q36066149)

12 August 2017

1 reference

title

Regulation of androgen receptor signaling in prostate cancer (English)

1 reference

12 August 2017

1 reference

Scott M Dehm

1

1 reference

PubMed ID

15757439

12 August 2017

Donald J Tindall

series ordinal

2

1 reference

12 August 2017

1 February 2005

1 reference

Expert Review of Anticancer Therapy

12 August 2017

1 reference

12 August 2017

5

1 reference

12 August 2017

63-74

1 reference

12 August 2017

1

1 reference

12 August 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

National Comprehensive Cancer Network guidelines for the management of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Structure/function analyses of human sex hormone-binding globulin: effects of zinc on steroid-binding specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen receptors and their biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Formation of the androgen receptor transcription complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Transcriptional coactivator complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Transcriptional programs activated by exposure of human prostate cancer cells to androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

The program of androgen-responsive genes in neoplastic prostate epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Identification and validation of novel androgen-regulated genes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Contribution of the androgen receptor to prostate cancer predisposition and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

The androgen axis in recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen receptor signaling in androgen-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Molecular basis of androgen insensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen receptor gene mutations in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen receptor mutations in high-grade prostate cancer before hormonal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen receptor alterations in prostate cancer relapsed during a combined androgen blockade by orchiectomy and bicalutamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

A novel androgen receptor mutant, A748T, exhibits hormone concentration-dependent defects in nuclear accumulation and activity despite normal hormone-binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

The androgen receptor gene mutations database (ARDB): 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen Receptor Gene Amplification and Protein Expression in Recurrent Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Molecular determinants for the tissue specificity of SERMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Selective estrogen receptor modulation: concept and consequences in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Antiandrogen Effects of Mifepristone on Coactivator and Corepressor Interactions with the Androgen Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Antiandrogens: selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Prostate cancer chemoprevention: an overview of United States trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

Pharmacodynamics of selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.63

21 January 2018

Identifiers

DOI

10.1586/14737140.5.1.63

1 reference

12 August 2017

1 reference

PubMed ID

15757439